AbbVie

AbbVie lives in the world of prescription medicines, especially immunology, oncology, and other specialty-drug lines, so its audience is patients, doctors, and the healthcare system rather than consumers at large. By our assessment, the company is good at turning deep medical research into branded therapies that can stay important for years, which is the sort of strength drugmakers are actually judged on. The trade-off is obvious: pharma depends on patents, regulation, clinical risk, and the constant need to replace older products with new ones. In practice, AbbVie is a research-and-commercialization business with a lot of technical language and a product mix that is much more serious than glamorous. It sits among the major biopharma names, not among simple drugstore brands. AbbVie is based in the United States.